Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.20.2
Concentrations
9 Months Ended
Sep. 30, 2020
Risks and Uncertainties [Abstract]  
Concentrations

Note 11 – Concentrations

 

Sales

 

During the nine months ended September 30, 2020, we had two significant customers which accounted for 36% and 20% of sales.

 

Supplier

 

We also have a single source for our bioelectric medical devices, which account for 100% of our sales. The interruption of products provided by this supplier would adversely affect our business and financial condition unless an alternative source of products could be found.

 

Accounts Receivable

 

At September 30, 2020, we had two customers which accounted for 100% of our account receivable balances.